# Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2

> **NCT05153850** · — · UNKNOWN · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 243 (estimated)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05153850
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 243 (ESTIMATED)
- **Last updated:** 2022-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05153850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05153850, "Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05153850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*